{
    "2018-11-21": [
        [
            {
                "time": "2018-03-15",
                "original_text": "AbbVie (ABBV) Shares Cross 5% Yield Mark",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Shares",
                        "5% Yield",
                        "Cross"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-21",
                "original_text": "AbbVie Receives US FDA Accelerated Approval for VENCLEXTAÂ® (venetoclax) for Treatment of Newly-Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "US FDA",
                        "Accelerated Approval",
                        "VENCLEXTA",
                        "Acute Myeloid Leukemia"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ABBV, MGTI, ACHC, JT and HTHT",
                "features": {
                    "keywords": [
                        "Klein Law Firm",
                        "Class Actions",
                        "Shareholders",
                        "ABBV"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "legal",
                        "investments"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-02-28",
                "original_text": "AbbVie (ABBV) Stock Moves -1.55%: What You Should Know",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Stock Moves",
                        "-1.55%"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}